title: Contaminant, or no contaminant, that is the question.
authors.affiliation: The Heart Centre, Royal Victoria Hospital, Belfast, UK. nickmckeag@googlemail.com
authors.forename: N A
authors.initials: NA
authors.lastname: McKeag
authors.forename: C J
authors.initials: CJ
authors.lastname: McCann
authors.forename: M J
authors.initials: MJ
authors.lastname: Daly
authors.forename: C M
authors.initials: CM
authors.lastname: Wilson
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001022:Aortic Valve Insufficiency / Q000382:microbiology* / Q000601:surgery; D003354:Corynebacterium Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use; D013345:Subarachnoid Hemorrhage / Q000382:microbiology*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D012293:Rifampin